OptimizeRx Corporation - Common Stock (OPRX)

OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript

Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at combining platforms and adding AI, investors are considering whether GitLab will be able to compete in the future of enterprise development.

This cloud-based software provider serves organizations worldwide with modular tools for work management and collaboration.

One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits.

One fund just walked away from BrightView — here’s what the numbers suggest long-term investors should really pay attention to.

One fast-growing software company just won a major vote of confidence — here’s what’s behind it.

One formerly high-flying alternative energy stock just got a surprising vote of confidence — here’s what the latest numbers reveal.

The investment firm sold all of its shares in the AI firm.

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript

OptimizeRx (OPRX) stock shows a powerful breakout setup, combining a strong technical uptrend with explosive earnings and sales growth momentum.

OptimizeRx Q3 earnings crush estimates with strong revenue and profit growth. The healthcare tech firm also raises its full-year 2025 guidance.

Discover how OptimizeRx (OPRX) exemplifies the Minervini Trend Template, combining strong technical momentum with explosive fundamental growth for a powerful stock setup.

UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes targeting its expansive vertical integration and Medicare Advantage billing practices are intensifying, while the company continues to reel from the catastrophic

OptimizeRx (OPRX) combines strong technical uptrend with explosive earnings growth, making it a top growth and momentum stock pick.

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

OptimizeRx's stock jumped 22.66% after hours following strong Q2 earnings that beat expectations and lifted the share price from $12.84 to $15.75.